Literature DB >> 16565076

New insights into BS69 functions.

Guillaume Velasco1, Steve Grkovic, Stéphane Ansieau.   

Abstract

The BS69 protein has been commonly described as a co-repressor associated with various transcription factors. However, this hypothesis relied predominantly on overexpression of tagged proteins due to the lack of a reliable BS69 antibody. We present for the first time a complete sequence of BS69 and valuable tools to characterize the endogenous protein. We show that the full-length BS69 protein, as well as minor alternatively spliced isoforms, is ubiquitously expressed, nuclear, and associates with chromatin and mitotic chromosomes. Accordingly, BS69 interacts with a set of chromatin remodeling factors, including ATP-dependent helicases, histone deacetylases, and histone methyltransferases, as well as the E2F6 transcription factor. These data strengthen a role for BS69 in gene repression and link BS69 to chromatin remodeling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565076     DOI: 10.1074/jbc.M600573200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing.

Authors:  Rui Guo; Lijuan Zheng; Juw Won Park; Ruitu Lv; Hao Chen; Fangfang Jiao; Wenqi Xu; Shirong Mu; Hong Wen; Jinsong Qiu; Zhentian Wang; Pengyuan Yang; Feizhen Wu; Jingyi Hui; Xiangdong Fu; Xiaobing Shi; Yujiang Geno Shi; Yi Xing; Fei Lan; Yang Shi
Journal:  Mol Cell       Date:  2014-09-25       Impact factor: 17.970

2.  Crystal structure of human BS69 Bromo-ZnF-PWWP reveals its role in H3K36me3 nucleosome binding.

Authors:  Juncheng Wang; Su Qin; Fudong Li; Sai Li; Wei Zhang; Junhui Peng; Zhiyong Zhang; Qingguo Gong; Jihui Wu; Yunyu Shi
Journal:  Cell Res       Date:  2014-03-28       Impact factor: 25.617

Review 3.  The Histone Variant H3.3 in Transcriptional Regulation and Human Disease.

Authors:  Leilei Shi; Hong Wen; Xiaobing Shi
Journal:  J Mol Biol       Date:  2016-11-26       Impact factor: 5.469

4.  Histone H3.3 and cancer: A potential reader connection.

Authors:  Fei Lan; Yang Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

5.  BS69 is involved in cellular senescence through the p53-p21Cip1 pathway.

Authors:  Wei Zhang; Ho Man Chan; Yan Gao; Randy Poon; Zhenguo Wu
Journal:  EMBO Rep       Date:  2007-08-24       Impact factor: 8.807

6.  Identification of transcriptionally regulated genes in response to cellular iron availability in rat hippocampus.

Authors:  Mei Liu; De-Sheng Xiao; Zhong-Ming Qian
Journal:  Mol Cell Biochem       Date:  2006-12-22       Impact factor: 3.842

7.  TOX4 and NOVA1 proteins are partners of the LEDGF PWWP domain and affect HIV-1 replication.

Authors:  Mehdi Morchikh; Monica Naughtin; Francesca Di Nunzio; Johan Xavier; Pierre Charneau; Yves Jacob; Marc Lavigne
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

8.  Structural and functional analysis of the DEAF-1 and BS69 MYND domains.

Authors:  Fatiha Kateb; Helene Perrin; Konstantinos Tripsianes; Peijian Zou; Roberta Spadaccini; Matthew Bottomley; Titus M Franzmann; Johannes Buchner; Stephane Ansieau; Michael Sattler
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

9.  The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity.

Authors:  Frank Schneider; Julia Neugebauer; Janine Griese; Nicola Liefold; Helmut Kutz; Cinthia Briseño; Arnd Kieser
Journal:  PLoS Biol       Date:  2008-01       Impact factor: 8.029

10.  Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching.

Authors:  Martin Philpott; Catherine M Rogers; Clarence Yapp; Chris Wells; Jean-Philippe Lambert; Claire Strain-Damerell; Nicola A Burgess-Brown; Anne-Claude Gingras; Stefan Knapp; Susanne Müller
Journal:  Epigenetics Chromatin       Date:  2014-07-13       Impact factor: 4.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.